| Literature DB >> 32334088 |
Abstract
Entities:
Keywords: Baricitinib; COVID-19; Corona virus cycle; Coronavirus; Coronaviruses; Drugs; Hydroxychloroquine; Remdesivir; SARS-CoV; SARS-CoV-2; Strategies; Targets; Therapies; Tocilizumab
Mesh:
Substances:
Year: 2020 PMID: 32334088 PMCID: PMC7175862 DOI: 10.1016/j.tmaid.2020.101685
Source DB: PubMed Journal: Travel Med Infect Dis ISSN: 1477-8939 Impact factor: 6.211